UPDATE: Canaccord Genuity Starts Penumbra (PEN) at Buy
Get Alerts PEN Hot Sheet
Rating Summary:
12 Buy, 6 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 11
Join SI Premium – FREE
Canaccord Genuity initiated coverage on Penumbra (NYSE: PEN) with a Buy rating and a price target of $48.
Analyst Jason Mills said, "There have been few times in our nearly two decades analyzing the med-tech industry that we have seen a small-cap company at the leading edge of a dramatic paradigm change in a large, untapped market, in which recently changed guidelines for patient treatment – favoring mechanical thrombectomy – align so attractively with PEN’s product offering. To wit, we believe the zeitgeist in acute ischemic stroke (AIS) intervention is one of those unique times, and we think PEN is positioned very well to capitalize on the growth and development of the interventional stroke market globally over the next several years."
For an analyst ratings summary and ratings history on Penumbra click here. For more ratings news on Penumbra click here.
Shares of Penumbra closed at $39.14 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Monness, Crespi, Hardt Downgrades Palantir Technologies Inc. (PLTR) to Sell on 'egregiously rich valuation... darkest days of this economic downturn are ahead of us'
- Safran SA (SAF:FP) (SAFRY) PT Raised to EUR211 at Citi, 'remain positive on the aftermarket'
- Braze Inc (BRZE) PT Lowered to $58 at Scotiabank, 'has done a very formidable job over the last ~12 months'
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, New CoverageRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!